Guidelines and Recommendations
The Puget Sound Health Alliance has identified guidelines and
developed recommendations for changing behaviors, activities and processes in
health care to improve effectiveness, affordability and value in health care.
The changes that the Alliance will recommend are intended to align incentives so
that everyone involved -- consumers, employers and other purchasers, physicians,
hospitals, health plans, and other health-related professionals and
organizations -- are more likely to engage in activities that promote good
health, reduce waste, and improve the affordability of health care.
Recommendations
Clinical
Guidelines
Recommendations
Principles
for Written Communication
The Puget
Sound Health Alliance adopted communication principles to help make health
information clear and easy for people to use. The Alliance uses these guidelines
and recommends that health providers, employers and others also use them. (Unanimously adopted by the Alliance Board on October 31, 2006)
For related resources visit www.WACommunityCheckup.org
Pharmaceutical
Company Sales Representatives in Clinics and Hospitals
The Puget Sound
Health Alliance strongly recommends that doctors, other providers and clinics or
physician groups not meet with pharmaceutical sales representatives in
facilities where patient care is provided. The Health Alliance encourages
doctors and other providers to adopt policies that significantly limit or
eliminate access of pharmaceutical sales representatives in clinic or hospital
locations. This limitation of access should include distribution of food, gifts,
branded office supplies, drug promotional materials, and pre-printed
prescription pads. (Unanimously adopted by the Alliance Board on May 30,
2006)
Use of Free Drug
Samples in Clinics and Hospitals
The
Puget Sound Health Alliance strongly recommends that doctors and other providers
and clinics or physician groups not accept or distribute
pharmaceutical samples in their practices. (Unanimously adopted by the
Alliance Board on May 30, 2006)
Supporting materials for both position
statements:
Position
Statement on Drug Company Sales Rep Visits in Clinics and Hospitals
Position Statement
on Distribution of Drug Samples in Clinics and Hospitals
Consumer
Advice on Rx Sales Visits and Distribution of Drug Samples
Programs
to Help with Access to Prescription Drugs for Low-Income Patients
Alliance
News Release: Open Door Policies for Drug Sales Reps and Free Samples Should be
Altered
Polyclinic
News Release
WA Academy of Family
Physicians Letter of Support
WA State Medical
Association Statement
Related Resources:
The American Medical Association enables providers to opt out of
the databases that pharmaceutical sales representatives use to track individual
providers’ prescribing practices. The AMA does not collect prescribing data, but
health information organizations use the AMA’s Physician Masterfile to match
providers with prescription data from other sources. In response to concerns
about these practices, the AMA has developed a program that makes it possible
for physicians to opt out of having their Masterfile information released for
sales purposes. To learn more or opt out, go to the AMA’s Physician Data
Restriction Program.
Clinical Guidelines
The Alliance Board of Directors has identified several areas of
focus for clinical improvement: heart disease, diabetes, back pain, depression,
asthma, prevention, and the use of pharmaceuticals. The work in most of these
areas has been completed by expert teams. These clinical improvement teams are
each charged with reviewing the research and identifying appropriate
evidence-based clinical guidelines that will create the foundation for the
regional Quality Performance Reports and the
recommended toolkits for improved clinical
performance and greater efficiency in health care.
Clinical
Improvement Reports for diabetes, heart disease, prescription drugs, back
pain and depression have been completed. We encourage everyone to read and use
the important information in each of these reports. |